D Adams, P Cintas, G Solé, C Tard, C Labeyrie, A Echaniz-Laguna, C Cauquil, Y Pereon, L Magy, R Juntas Morales, J C Antoine, E Lagrange, P Petiot, M Mallaret, B Francou, A Guiochon-Mantel, A Coste, O Demarcq, C Geffroy, V Famelart, J Rudant, M Bartoli, E Donal, O Lairez, J C Eicher, M Kharoubi, S Oghina, J N Trochu, J Inamo, G Habib, F Roubille, A Hagège, F Morio, E Cariou, J Adda, M S Slama, P Charron, V Algalarrondo, T Damy, S Attarian
OBJECTIVE: We aimed to describe characteristics of patients with ATTR variant polyneuropathy (ATTRv-PN) and ATTRv-mixed and assess the real-world use and safety profile of tafamidis meglumine 20mg. METHODS: Thirty-eight French hospitals were invited. Patient files were reviewed to identify clinical manifestations, diagnostic methods, and treatment compliance. RESULTS: Four hundred and thirteen patients (296 ATTRv-PN, 117 ATTRv-mixed) were analyzed...
April 19, 2024: Revue Neurologique